Enliven Therapeutics Inc.
Enliven Therapeutics Inc.
World Rank (Aug-2026)
3997
Market Cap (Aug-2026)
4.310 Billion USD
Market Cap (Mar-08-2026)
1.761 Billion USD
World Rank (Jan-05-2024)
11,471
Market Cap (Jan-05-2024)
0.601 Billion USD
World Rank (Jul-30-2023)
11,455
Market Cap (Jul-30-2023)
0.612 Billion USD
Headquarters Country
Nasdaq / NYSE Code
ELVN
Annual Net Income in USD
-104 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
476 Million USD
Total Liabilities in USD
17 Million USD
Total Equity in USD
460 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Company Website
Ads